Shell US chemicals assets sale
Analysis based on 9 articles · First reported Aug 24, 2026 · Last updated Aug 24, 2026
The potential sale of Shell's US chemicals assets for up to $8 billion could signal a strategic shift by Shell towards higher-margin upstream and trading activities, potentially boosting investor sentiment. The interest from major industry players and private equity may indicate consolidation in the chemicals sector, with potential implications for asset valuations and competitive dynamics.
Shell plc is seeking to sell its US chemicals assets, which could fetch up to $8 billion, according to the Financial Times. The assets include plants at four sites in Louisiana, Texas, and Pennsylvania, producing chemicals used in plastics, detergents, and pharmaceuticals. Potential buyers, including ExxonMobil, LyondellBasell, Apollo Global Management, and the chemicals arm of Bharat Petroleum, have expressed interest and submitted non-binding bids last month. The reported valuation represents a steep discount to Shell's capital investment in these facilities. This divestiture aligns with Shell's strategy to focus on upstream operations and trading, following its recent sale of its European onshore renewables business to TotalEnergies.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard